Antibiotic treatment in nasal septal surgery

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-018031-90-SE

Enrollment

250

Registered

2009-12-17

Start date

2010-09-09

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal septal surgery (NSS) is in Sweden made with or without antibiotic prophylaxis. The condition to be studied is to see if there are more postoperative infectioins if given or not antibiotic prophylaxis.

Interventions

Trade Name: Ekvacillin Product Name: Kloxacillin Pharmaceutical Form: Injection* Trade Name: Ekvacillin, Astra - Zeneca Product Name: Kloxacillin Pharmaceutical Form: Intravenous infusion Pharmaceut

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Less than 18 years Psycological desease lowered immune defence

Design outcomes

Primary

Measure	Time frame
Main Objective: To see if antibiotic profylaxis is necessary to prevent the frequence of postoperative infections after NSS;Secondary Objective: ;Primary end point(s): If the patient will have or not a postoperative infection within 10 days after the operation.	—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026